---
layout: minimal-medicine
title: Anti-D (RH) Immunoglobulin
---

# Anti-D (RH) Immunoglobulin
### Generic Name
Anti-D (Rh) Immunoglobulin

### Usage

Anti-D (Rh) immunoglobulin is a crucial medication primarily used to prevent RhD isoimmunization in RhD-negative mothers who are pregnant with or have delivered an RhD-positive baby.  RhD isoimmunization occurs when the mother develops antibodies against the RhD antigen present in the baby's blood, potentially leading to hemolytic disease of the newborn (HDN) in future pregnancies.  This medication works by suppressing the mother's immune response, preventing the formation of these harmful antibodies.

Beyond pregnancy, Anti-D (Rh) immunoglobulin also has a significant role in treating immune thrombocytopenic purpura (ITP), a condition characterized by low platelet counts.  In ITP, the body mistakenly attacks its own platelets, leading to easy bruising and bleeding.  This medication can help increase platelet levels by modulating the immune system's response to platelets.  It's important to note that its use in ITP is limited to Rh-positive, non-splenectomized patients.  The medication may also be used after incompatible blood transfusions to prevent an immune response.


### Dosage

Dosage for Anti-D (Rh) immunoglobulin varies considerably depending on the indication (pregnancy, ITP, or post-transfusion) and the patient's specific circumstances.  Always consult the prescribing information accompanying the specific product used, as variations exist between different brands. The following information provides general guidelines and should not replace professional medical advice:


**For RhD Isoimmunization Prevention in Pregnancy:**

* **Antenatal Prophylaxis:**  A typical regimen involves 500 IU administered at 28 and 34 weeks of gestation, or a single dose of 1500 IU between 28-30 weeks.  Dosage may vary; refer to product labeling.  Additional doses may be necessary following potential sensitizing events like miscarriage or amniocentesis.
* **Postnatal Prophylaxis:**  A standard dose is 500 IU administered as soon as possible after delivery of an RhD-positive infant.  Higher doses may be required if significant fetomaternal hemorrhage (FMH) is detected (determined by tests like Kleihauer-Betke).

**For Immune Thrombocytopenic Purpura (ITP):**

* **Initial Dose (IV):**  The initial dose is typically 250 IU/kg (50 mcg/kg) as a single dose or split over two days. Lower doses (125-200 IU/kg) might be used if the patient has pre-existing anemia (hemoglobin <10 g/dL).
* **Maintenance Dose (IV):**  This is determined based on clinical response and platelet count, usually ranging from 125-300 IU/kg (25-60 mcg/kg).

**Post-Transfusion Prophylaxis:**

* The recommended dose is 100 IU per 2 mL of transfused RhD-positive blood, with a maximum of 15000 units.


**Administration:** Intramuscular (IM) injection is common for pregnancy-related prophylaxis, while intravenous (IV) administration is typical for ITP treatment.  Always follow the specific administration instructions provided with the medication.


### Side Effects

Common side effects, typically mild, may include:

* Headache
* Chills
* Fever
* Injection site pain or redness
* Dizziness
* Fatigue

Less common, but potentially serious, side effects may involve:

* Allergic reactions (anaphylaxis)
* Intravascular hemolysis (particularly in ITP treatment)
* Acute renal failure
* Decreased hemoglobin levels
* Thrombotic events (in ITP treatment)

Seek immediate medical attention if you experience any serious or concerning side effects.

### How it Works

Anti-D (Rh) immunoglobulin contains antibodies against the RhD antigen. In pregnancy, these antibodies bind to any fetal RhD-positive red blood cells that might have entered the mother's circulation, preventing her immune system from recognizing them as foreign and triggering an antibody response.  This prevents sensitization and the subsequent development of harmful antibodies that could affect future pregnancies.  In ITP, the mechanism isn't fully understood but is thought to involve interference with the immune system's attack on platelets, increasing their lifespan.

### Precautions

* **Hypersensitivity:** Anti-D (Rh) immunoglobulin is contraindicated in individuals with known hypersensitivity to human immune globulins or IgA deficiency with anti-IgA antibodies.
* **Pregnancy and Breastfeeding:**  While used to prevent HDN in pregnancy, it's classified as pregnancy category C. Consult a healthcare provider before using this medication if you are pregnant, breastfeeding, or plan to become pregnant.
* **Renal and Hepatic Impairment:**  No specific dose adjustments are currently recommended for individuals with renal or hepatic impairment; use with caution.
* **ITP Treatment:**  Use in ITP is limited to RhD-positive, non-splenectomized individuals and requires close monitoring for intravascular hemolysis.
* **Drug Interactions:** No clinically significant interactions have been widely reported. Still, inform your doctor about all medications you are taking.

### FAQs

* **Q: Is Anti-D (Rh) immunoglobulin safe?**  A: It's generally safe and effective when administered correctly. However, like all medications, it carries potential risks, and careful monitoring is sometimes necessary.
* **Q: How is it stored?** A: Typically stored at refrigerator temperature (2-8Â°C). Always refer to the product label for specific storage instructions.
* **Q: What if I miss a dose?** A: Contact your healthcare provider immediately for guidance.
* **Q: Are there any long-term effects?** A:  Long-term effects are rare, but potential risks should be discussed with your healthcare provider.
* **Q: Can I take other medications concurrently?** A: Always inform your healthcare provider of all medications, supplements, and herbal remedies you're taking.

**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult a healthcare professional for diagnosis, treatment, and any questions regarding your health or medication.  The information provided here is based on generally accepted medical knowledge and may not cover all possible uses, side effects, interactions, or precautions.  Always refer to the latest product information for accurate and complete data.
